Gefitinib Impurity IV HCl - Request Quote
Gefitinib Impurity IV HCl
| SZ CAT No: | SZ-G018013 |
| CAS No | NA |
| Mol.F. | C22H24Cl2N4O3 : HCl |
| Mol.Wt. | 463.4 : 36.5 |
| Inv. Status | In Stock |
| Rel. CAS No | 2089650-13-3 (free base) |
Chemical Name :
Shipping Temperature :
HSN Code :
Country of Origin :
Smiles :
Usage Note:
Gefitinib Impurity IV HCl is chemically N-(3,4-Dichlorophenyl)-7-methoxy-6-(3-morpholinopropoxy)quinazolin-4-amine hydrochloride. Gefitinib Impurity IV HCl is supplied with detailed characterization data compliant with regulatory guideline. Gefitinib Impurity IV HCl can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Gefitinib.
The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.
Applications & Regulatory Use Cases
buy high quality Gefitinib Impurity IV HCl
Purchase Gefitinib Impurity IV HCl
Gefitinib Impurity IV HCl suppliers
Gefitinib Impurity IV HCl manufacturers
Gefitinib Impurity IV HCl price
Order Gefitinib Impurity IV HCl
Enquire Gefitinib Impurity IV HCl
Gefitinib Impurity IV HCl cost
Gefitinib Impurity IV HCl Supplier
Gefitinib Impurity IV HCl Distributor
Gefitinib Impurity IV HCl for Method Validation
Gefitinib Reference Standard
Gefitinib Impurity IV HCl for ANDA Filing
Gefitinib Impurity IV HCl for Forced Degradation Studies
Gefitinib Impurity IV HCl Identification Standards
Gefitinib Impurity IV HCl for DMF Filing
Related Products
Disclaimer
SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.
SynZeal will update these details as per new developments or findings in product specifications without further notice.